The company said in its Form 8-K filed on September 11, 2025 that it submitted, under Item 9.01, Exhibit 5.01 (Opinion of Karen Wang, Esq.), Exhibit 99.01 (list of securities registered under Section 12(b)), and Exhibit 104 (Inline XBRL cover page) as attachments.

1. 01

   The company said in its Form 8-K filed on September 11, 2025 that it submitted, under Item 9.01, Exhibit 5.01 (Opinion of Karen Wang, Esq.), Exhibit 99.01 (list of securities registered under Section 12(b)), and Exhibit 104 (Inline XBRL cover page) as attachments.

2. 02

   The company said the report was filed on September 11, 2025 with the signature of Karen Wang, Assistant Secretary (/s/Karen Wang). Exhibit 5.01, an opinion of Karen Wang, Esq., is also listed.

3. 03

   Citigroup said Exhibit 99.01 lists its common stock, par value $.01 per share (ticker C), along with 7.625% Trust Preferred Securities of Citigroup Capital III (C/36Y) and 7.875% Fixed Rate / Floating Rate Trust Preferred Securities of Citigroup Capital XIII (C N), as registered on the New York Stock Exchange.

4. 04

   The company said Exhibit 99.01 lists 5 series of CGMHI Medium-Term Senior Notes, Series N, floating rate notes, due September 17, 2026, April 26, 2028, September 15, 2028, October 6, 2028 and March 21, 2029, as securities registered on the New York Stock Exchange with the registrant's guaranty.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.